Human lens epithelial cell damage and stimulation of their secretion of chemical mediators by benzalkonium chloride rather than latanoprost and timolol

Archives of Ophthalmology

Volumn 121, Issue 6, 2003, Pages 835-839

  Goto, Yoko ^a   Ibaraki, Nobuhiro ^a   Miyake, Kensaku ^b  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b Miyake Eye Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZALKONIUM CHLORIDE; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; IODINE 125; LATANOPROST; PROSTAGLANDIN E2; TIMOLOL;

ARTICLE; CELL CULTURE; CELL DAMAGE; CELL PROLIFERATION; CELL STIMULATION; CELL STRUCTURE; CHEMOLUMINESCENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LENS EPITHELIUM; PHASE CONTRAST MICROSCOPE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STRESS; WOUND HEALING;

ANTIHYPERTENSIVE AGENTS; BENZALKONIUM COMPOUNDS; CELL LINE, TRANSFORMED; DINOPROSTONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; LENS, CRYSTALLINE; MICROSCOPY, PHASE-CONTRAST; PRESERVATIVES, PHARMACEUTICAL; PROSTAGLANDINS F, SYNTHETIC; RADIOIMMUNOASSAY; TIMOLOL;

EID: 0037672860     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.121.6.835     Document Type: Article

References (23)

1. Sherwood MB, Grierson I, Millar L, Hitchings RA. Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon's capsule in glaucomatous patients. Ophthalmology. 1989;96:327-335.
2. Brandt JD, Wittpenn JR, Katz LJ, Steinmann WN, Spaeth GL. Conjunctival impression cytology in patients with glaucoma using long-term topical medication. Am J Ophthalmol. 1991;112:297-301.
3. Broadway D, Grierson I, Hitching R. Adverse effects of topical antiglaucomatous medications on the conjunctiva. Br J Ophthalmol. 1993;77:590-596.
4. Liesegang TJ. Conjunctival changes associated with glaucoma therapy: implications for the external disease consultant and the treatment of glaucoma. Cornea. 1998;17:574-583.
5. Baudouin C, Pisella PJ, Fillacier K, et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies. Ophthalmology. 1999;106:556-563.
6. Kamei Y, Fujisawa S, Tetsuka S, et al. Effects of preservatives of bacteria. J Jpn Contant Lens Soc. 1993;35:231-237.
7. de Saint Jean M, Debbasch C, Brignole F, et al. Toxicity of preserved and unpreserved β-blocker eyedrops in an in vitro model of human conjunctival cells. J Fr Ophtalmol. 2000;23:111-121.
8. Pissella PJ, Fillacier K, Elena PP, Debbasch C, Baudouin C. Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits. Ophthalmic Res. 2000;32:3-8.
9. Miyake K, Ota I, Maekubo K, Ichihashi S, Miyake S. Latanoprost accelerates disruption of blood-aqueous barrier and the incidence of angiographic cystoid macular edema in early postoperative pseudophakias. Arch Ophthalmol. 1999;117: 34-40.
10. Miyake K, Ota I, Ibaraki N, et al. Enhanced disruption of blood-aqueous barrier and the incidence of angiographic cystoid macular edema by topical timolol and its preservative in early postoperative pseudophakia. Arch Ophthalmol. 2001; 119:387-394.
11. Miyake K, Mibu H, Horiguchi M, Shirasawa E. Inflammatory mediators in post-operative aphakic and pseudophakic baboon eyes. Arch Ophthalmol. 1990;108: 1764-1767.
12. 2 by lens epithelial cells of human cataracts. Br J Ophthalmol. 1992;76:338-341.
13. Ibaraki N, Chen S-C, Lin L-R, et al. Human lens epithelial cell line. Exp Eye Res. 1998;67:577-585.
14. Ibaraki N. Human lens epithelial cell culture. In: Wise C, ed. Epithelial Cell Culture Protocols. Totowa, NJ: Humana Press Inc. 2002:1-6. Methods in Molecular Biology, vol 188.
15. Leske MC, Wu S-Y, Nemesure B, et al. Risk factors for incident nuclear opacities. Ophthalmology. 2002;109:1303-1308.
16. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: result from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268-1279.
17. Kass MA, Heuer DK, Higginbotham EJ, et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713.
18. Araie M, Takase M, Yokoyama Y, Kitagawa M. Timolol maleate: pharmacokinetic analysis of ocular penetration in the rabbit eye and effects on human aqueous humor dynamics [in Japanese]. Nippon Ganka Gakkai Zasshi. 1980;84:2139-2146.
19. Mizuno K, Koide T, Yoshimura M, Araie M. Neuroprotective effect and intraocular penetration of nipradilol, a β-blocker with nitric oxide donative action. Invest Ophthalmol Vis Sci. 2001;42:688-694.
20. Sjoquist B, Johansson A, Stjernschantz J. Pharmacokinetics of latanoprost in the cynomolgus monkey, 3rd communication: tissue distribution after topical administration of the eye studies by whole body autoradiography. Arzneimittelforschung. 1999;49:240-249.
21. Acheampong AA, Breau A, Shackleton M, et al. Comparison of concentration time profiles of levobunolol and timolol in anterior and posterior ocular tissues of albino rabbits. J Ocul Pharmacol Ther. 1995;11:489-502.
22. 2 synthetase (cyclooxygenase) in human monocytes. J Biol Chem. 1990; 265:16737-16740.
23. Miyake K. Prevention of cystoid macular edema after lens extraction by topical indomethacin, I: a preliminary report. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1977;203:81-88.